Advertisement

Cancer Causes & Control

, Volume 15, Issue 6, pp 611–618 | Cite as

Estimating Regional Variation in Cancer Survival: A Tool for Improving Cancer Care

  • Xue Q. Yu
  • Dianne L. O'Connell
  • Robert W. Gibberd
  • David P. Smith
  • Paul W. Dickman
  • Bruce K. Armstrong
Article

Abstract

Objective: To improve estimation of regional variation in cancer survival and identify cancers to which priority might be given to increase survival.

Methods: Survival measures were calculated for 25 major cancer types diagnosed in each of 17 health service regions in New South Wales, Australia, from 1991 to 1998. Region-specific risks of excess death due to cancer were estimated adjusting for age, sex, and extent of disease at, and years since, diagnosis. Empirical Bayes (EB) methods were used to shrink the estimates. The additional numbers of patients who would survive beyond five years were estimated by shifting the State average risk to the 20th centile.

Results: Statistically significant regional variation in the shrunken estimates of risk of excess death was found for nine of the 25 cancer types. The lives of 2903 people (6.4%) out of the 45,047 whose deaths within 5 years were attributable to cancer could be extended with the highest number being for lung cancer (791).

Conclusions: The EB approach gives more precise estimates of region-specific risk of excess death and is preferable to standard methods for identifying cancer sites where gains in survival might be made. The estimated number of lives that could be extended can assist health authorities in prioritising investigation of and attention to causes of regional variation in survival.

cancer empirical Bayes methods regional variation relative survival 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dickman PW, Gibberd RW, Hakulinen T (1997) Estimating potential savings in cancer deaths by eliminating regional and social class variation in cancer survival in the Nordic countries.J Epidemiol Commun Health 51: 289–298.Google Scholar
  2. 2.
    Farrow DC, Samet JM, Hunt WC (1996) Regional variation in survival following the diagnosis of cancer. J Clin Epidemiol 49: 843–847.CrossRefPubMedGoogle Scholar
  3. 3.
    Twelves CJ, Thomson CS, Dewar JA, Brewster DH (2001) Variation in survival of women with breast cancer: Health Board remains a factor at 10 years. Br J Cancer 85: 637–640.CrossRefPubMedGoogle Scholar
  4. 4.
    The Canadian Institute for Health Information. Location plays role in cancer survival: study. Available at: http://www.cbc.ca/ stories/2002/05/30/cancer_report020530, accessibility verified June 13, 2002.Google Scholar
  5. 5.
    Cole P, Morrison AS (1980) Basic issues in population screening for cancer. J Natl Cancer Inst 64: 1263–1272.PubMedGoogle Scholar
  6. 6.
    Black WC, Welch HG (1993) Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy.N Engl J Med 328: 1237–1243.CrossRefPubMedGoogle Scholar
  7. 7.
    Jacobson B, Mindell J, McKee M (2003) Hospital mortality league tables: question what they tell you-and how useful they are. BMJ 326: 777–778.PubMedGoogle Scholar
  8. 8.
    Efron B, Morris C (1975) Data analysis using Stein's estimator and its generalizations. J Am Stat Assoc 70: 311–319.Google Scholar
  9. 9.
    Christiansen CL, Morris CN (1997) Improving the statistical approach to health care provider profiling. Annal Int Med 127: 764–768.Google Scholar
  10. 10.
    Gibberd R, Pathmeswaran A, Burtenshaw K (2000) Using clinical indicators to identify areas for quality improvement. J Qual Clin Practice 20: 136–144.CrossRefGoogle Scholar
  11. 11.
    Spiegelhalter DJ, Myles JP, Jones DR, et al. (1999) An introduction to Bayesian methods in health technology assessment. BMJ 319: 508–512.PubMedGoogle Scholar
  12. 12.
    Brenner H, Soderman B, Hakulinen T (2002) Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland. Int J Epidemiol 31: 456–462.PubMedGoogle Scholar
  13. 13.
    Ederer F, Axtell LM, Cutler SJ (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monograph 6: 101–121.Google Scholar
  14. 14.
    Chiang CL (1968) Introduction to Stochastic Processes in Biostatistics.New York: John Wiley.Google Scholar
  15. 15.
    Ederer F, Heise H (1959) Instructions to IMB 650 programmers in processing survival computations. Methodological Note No. 10, End Results Evaluation Section. Bethesda, MD: National Cancer Institute.Google Scholar
  16. 16.
    Voutilainen ET, Dickman PW, Hakulinen T (2000) SURV2: Relative Survival Analysis Program. Software Manual (Version2.02β). Helsinki: Finnish Cancer Registry.Google Scholar
  17. 17.
    Suissa S (1999) Relative excess risk: an alternative measure of comparative risk. Am J Epidemiol 150: 279–282.PubMedGoogle Scholar
  18. 18.
    Cancer Strategies Group (2001) Priorities for Action in Cancer Control 2001-2003. Canberra: Commonwealth of Aistralia, pp. 9–12.Google Scholar
  19. 19.
    Howley P, Gibberd R (2003) Using hierarchical models to analyse clinical indicators: a comparison of the gamma-Poisson and betabinomial models. Int J Qual Health Care 15: 919–929.CrossRefGoogle Scholar
  20. 20.
    Aistralian Council on Healthcare Standards (2003) Determining the Potential to Improve the Quality of Care, 3rd edn. ACHS Clinical Indicator Results for Aistralia and New Zealand 1998-2001. Sydney: The Aistralian Council on Healthcare Standards.Google Scholar
  21. 21.
    Supramaniam R, Smith DP, Coates MS, Armstrong BK (1999) Survival from Cancer in New South Wales in 1980 to 1995. Sydney: NSW Cancer Council.Google Scholar
  22. 22.
    Clinical Governance Unit (2002) The National Colorectal Cancer Care Survey. Aistralian Clinical Practice in 2000. Melbourne: National Cancer Control Initiative.Google Scholar
  23. 23.
    Accounts Commission for Scotland (1998) Fighting the Silent Killer: Optimising Ovarian Cancer Management in Scotland.Edinburgh: Accounts Commission for Scotland.Google Scholar
  24. 24.
    Goodwin JS, Freeman JL, Mahnken JD, Freeman DH, Nattinger AB (2002) Geographic variations in breast cancer survival among older women: implications for quality of breast cancer care.J Gerontol A Biol Sci Med Sci 57: M401–M406.PubMedGoogle Scholar
  25. 25.
    Cartman ML, Hatfield AC, Muers MF, Peake MD, Haward RA, Forman D (2002) Lung cancer: district active treatment rates affect survival. J Epidemiol Commun. Health 56: 424–429.CrossRefGoogle Scholar
  26. 26.
    Karjalainen S (1990) Geographical variation in cancer patient survival in Finland: chance, confounding, or effect of treatment? J Epidemiol Community Health 44: 210–214.PubMedGoogle Scholar
  27. 27.
    Campbell NC, Elliott AM, Sharp L, Ritchie LD, Cassidy J, Little J (2000) Rural factors and survival from cancer: analysis of Scottish cancer registrations. Br J Cancer 82: 1863–1866.PubMedGoogle Scholar
  28. 28.
    Gatta G, Buiatti E, Conti E, et al. (1997) Variations in the survival of adult cancer patients in Italy. Tumori 83: 497–504.PubMedGoogle Scholar
  29. 29.
    Madsen FF, Norskov B, Frolund L, Hanash JA (2002) Lung cancer: survival rate differences in Danish counties. Survival analysis of 33,838 patients during the period 1984-1998. Ugeskr Laeger 164: 483–487.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Xue Q. Yu
    • 1
  • Dianne L. O'Connell
    • 1
  • Robert W. Gibberd
    • 2
  • David P. Smith
    • 1
  • Paul W. Dickman
    • 3
  • Bruce K. Armstrong
    • 4
  1. 1.Cancer Epidemiology Research UnitThe Cancer CouncilKings CrossAustralia
  2. 2.Health Services Research Group, Faculty of Medicine and Health SciencesUniversity of NewcastleAustralia
  3. 3.Department of Medical EpidemiologyKarolinskat InstitutetSweden
  4. 4.School of Public HealthThe University of SydneyAustralia

Personalised recommendations